[Clinical Value of Dual Tracer PET Imaging With <sup>68</sup>Ga-PSMA and <sup>18</sup>F-FDG in Patients With Metastatic Prostate Cancer].
Dual-tracer PET/CT imaging with <sup>68</sup>Ga-PSMA and <sup>18</sup>F-FDG commonly exhibits avidity for both tracers in mPCa. Serum PSA level is a reliable biomarker for predicting FDG-positive lesions. mPCa presented with intraductal carcinoma and neuroendocrine differentiation tends to exhibit FDG avidity and is more susceptible to PSA progression.
Authors
- Qiang Wei (ORCID: https://orcid.org/0000-0001-5925-6922)
- Rui Huang (ORCID: https://orcid.org/0000-0003-3191-0528)
- Shuhui Huang
- Hao Zeng (ORCID: https://orcid.org/0000-0003-0818-8151)
- Tian Tian (ORCID: https://orcid.org/0000-0002-9692-750X)
- Hongyuan Dai (ORCID: https://orcid.org/0000-0002-2013-2196)
- Naifeng Hou
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-09-20
- DOI
- https://doi.org/10.12182/20240960201
- Citations
- 3
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article